ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Mid-Level Backend Software Engineer at Side - ApplyBlast

Mid-Level Backend Software Engineer

Side

7 months ago

3.1 on Glassdoor

San Francisco, California, United States

Hybrid

Full Time

Medior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Mid-Level Backend Software Engineer will build and maintain backend services and APIs that support payment and commission workflows, collaborating with product and cross‑functional partners to deliver reliable, scalable solutions. The role involves independent feature delivery, system design participation, code quality, testing, and troubleshooting production issues while leveraging AI‑assisted development tools.

Responsibilities

Build and maintain backend services and APIs for payment workflows
Collaborate with product and cross‑functional partners to translate requirements into technical solutions
Troubleshoot production issues and ensure operational excellence

Skills

About Side

side.inc

Headquarters

London, England, United Kingdom

Company Size

1-10 employees

Founded

2009

View Profile

Side Inc. is a global leader in providing quality assurance, art, localization, player support, game development, and audio production services for the gaming industry. With an award-winning team, they partner with game developers to enhance their projects and bring creative visions to life. Their comprehensive range of services ensures that clients receive expert support in every aspect of game production, contributing to the successful launch and engagement of gaming titles worldwide.

Recent company news

Facebook

Ozempic started the weight-loss drug frenzy, and it continues to be a famous name in the fight against obesity, but the FDA has issued a warning letter to its maker, Novo Nordisk, for failing to report potential side effects in patients who took this medication. #oz

1 hour ago